HESPERIA, CA / ACCESS Newswire / December 17, 2025 / 5E Advanced Materials, Inc. (“5E” or the “Company”) (Nasdaq:FEAM)(ASX:5EA), a U.S. development-stage company focused on becoming a vertically ...

WASHINGTON, Dec 18 (Reuters) - U.S. President Donald Trump's administration has launched a review that could result in the first shipments to China of Nvidia's second-most powerful AI chips, five ...

Rohit Prasad is stepping down, while Amazon puts Peter DeSantis in charge of AI models, chips, and quantum computing. Rohit Prasad is stepping down, while Amazon puts Peter DeSantis in charge of AI ...

Automotive-qualified solutions for more intuitive, immersive in-vehicle experiences Cirrus Logic (NASDAQ: CRUS), a leading provider of high-performance audio and mixed-signal semiconductor solutions, ...

BETHLEHEM, Pa. — Pat McQuade hit Braden Reed with a 28-yard touchdown pass with just under three minutes to play as No. 12 Villanova beat fifth-seeded Lehigh 14-7 on the road. Lehigh drove down to the ...

Which language has the best loops? See for yourself, with our side-by-side (loop-for-loop) Python vs. Kotlin showdown. Find more stories in this week’s report.

Mobileye's ADAS business remains solid, but the lack of advanced program wins is weighing on the stock. This appears to be more due to a lack of OEM appetite than Mobileye-specific issues, though.

Allen Control Systems (ACS), a leader in autonomous precision robotics, today announced the release of Treillis, its next-generation Hardware-in-the-Loop (HIL) test platform purpose-built for ...

AUSTIN, Texas--(BUSINESS WIRE)--Allen Control Systems (ACS), a leader in autonomous precision robotics, today announced the release of Treillis, its next-generation Hardware-in-the-Loop (HIL) test ...

U.S. stocks opened mostly higher on Friday as the S&P 500 tried for a fifth straight advance at the close of what has been another strong week for stocks. On the news front, investors digested a ...

Madrigal Pharmaceuticals' Rezdiffra generated sales of $287 million in the third quarter for a 35% sequential jump from Q2. In just its fifth full quarter on the market, the world’s first treatment ...